| Ember Ann Skidmore, PHARMD | |
|
101 Bodin Cir Bldg 777, Travis Afb, CA 94535-1809 | |
| (707) 423-3000 | |
| Not Available |
| Full Name | Ember Ann Skidmore |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 Bodin Cir Bldg 777, Travis Afb, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043975469 | NPI | - | NPPES |
| 37625 | Other | CA | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 37625 (California) | Primary |
| 1835G0303X | Pharmacist - Geriatric | 37625 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ember Ann Skidmore, PHARMD 101 Bodin Cir Bldg 777, Travis Afb, CA 94535-1809 Ph: (707) 423-3000 | Ember Ann Skidmore, PHARMD 101 Bodin Cir Bldg 777, Travis Afb, CA 94535-1809 Ph: (707) 423-3000 |
News Archive
Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.
IDEV Technologies, Incorporated, an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks patients treated with the SUPERA wire interwoven nitinol stent.
Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a subsidiary of Valeant Pharmaceuticals International. The preparation is the first generic version of Sanofi Aventis' BenzaClin(R) to be approved by the U.S. Food and Drug Administration (FDA).
The Institute of Medicine's Panel on Adverse Effects of Vaccines issued a report today on the evidence and causality of vaccine harms. Despite a glowing press release, the report does little to allay public concerns over adverse effects of vaccines and suggests that we urgently need more science on vaccine adverse effects.
aTyr Pharma, a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address rare diseases, announced today that Resolaris has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for the treatment of facioscapulohumeral muscular dystrophy (FSHD).
› Verified 9 days ago
Dr. Joscelyn D. A. C. Aquiningoc, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 626-297-8649 | |
Dr. Fernando Estrada, PHARMD, BCPS, BCIDP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-3000 | |
Miss Margaret Ellen Lopresti Martin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Cir, 60 Mdg/sgqp, Travis Afb, CA 94535 Phone: 707-423-7656 | |
Sophia Kyein Kang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-7119 | |
Mr. Parag P Agarwal, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Cir, Travis Afb, CA 94535 Phone: 707-423-7657 | |
Rin Okano, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Bodin Circle, David Grant Medical Center, Travis Afb, CA 94534 Phone: 707-423-7656 |